Celogics logo

Celogics

Quality Cells, Quality Research. Providing iPSC differentiation services for pharmaceutical research

3 employees · est. 2021 · Seattle, United States

VS
Curi Bio logo

Curi Bio

Human Data for Next Generation Medicines

59 employees · est. 2015 · Seattle, United States

Curi Bio is the older company (2021 vs 2015); Curi Bio is the larger of the two.

Side-by-Side Comparison

Celogics Curi Bio
Founded
2021 2015 older
Headquarters
Seattle, United States Seattle, United States
Employees
3 59 larger
Industry
Biotechnology, Manufacturing AI, Biopharma, Biotechnology
Funding Stage
Not tracked yet Grant
Total Funding
Not tracked yet $20.40M
Funding Rounds
Not tracked yet 3
Services
Custom Cardiomyocytes Development, High-Quality Human iPSC-derived Cell Products, Drug Development Acceleration, Disease Modeling Research Not tracked yet
Target Customers
Pharmaceutical Companies, Biotech Researchers, Medical Research Institutions, Disease Modelers Not tracked yet
Taxonomy
IPSC Differentiation, Pharmaceutical Research, Human Cell Culture, Research-use-only Cell Products, Drug Discovery, Drug Safety Screening, Disease Modeling, IPSC-derived Cells, Life Sciences, Functional Cell Models, Celo.Cells Brand, Biotechnology Joint Venture, Cell Manufacturing, Validated Data Provision, Cell Model Innovation 3D Tissue Models, Biosystems, AI/ML-enabled Insights, Drug Safety, Efficacy, Potency, Tissue Engineering, Stem Cell Biology, Mechanobiology, Drug Screening, Drug Development, High-throughput Screening, IPSC-CM, Disease Modeling
Website
celogics.com curibio.com
Celogics logo

About Celogics

Celogics, founded in 2021, is carving a niche in the biotechnology and manufacturing sectors by pioneering advanced iPSC differentiation services tailored for pharmaceutical research. With the mission of enhancing the quality of human cell culture, Celogics aims to revolutionize research by producin...

Curi Bio logo

About Curi Bio

Curi Bio is a biopharma and biotechnology startup founded in 2015 with the slogan "Human Data for Next Generation Medicines." The company focuses on unlocking novel workflows and critical human data to inform R&D decision-making. Through an integrated platform, which includes advanced 3D tissue mode...

We will tell you when either one moves

BounceWatch watches Celogics and Curi Bio for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Celogics and Curi Bio — by email.

Frequently Asked Questions

Celogics — Quality Cells, Quality Research. Providing iPSC differentiation services for pharmaceutical research. Curi Bio — Human Data for Next Generation Medicines. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Celogics has raised undisclosed funding while Curi Bio has raised $20.40M.
Celogics and Curi Bio operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Celogics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Celogics on 4 Mar 2026, and Curi Bio on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy